Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
April 28, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 13, 2023
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
March 31, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 15, 2023
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
March 9, 2023
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
February 28, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 1, 2023
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
January 31, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 30, 2022
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 10, 2022
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page next ›
  • Last page last »
Displaying 51 - 60 of 148

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2024 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.